Navigation Links
3 Michigan Counties Participating in NIH Study of Cardiac Arrest Resuscitation Techniques
Date:10/13/2008

New 1.5 million dollar NIH funding advances study

Study needed because of low cardiac arrest survival rates

MINNEAPOLIS, Oct. 13 /PRNewswire/ -- Advanced Circulatory Systems, Inc. (http://www.advancedcirculatory.com) announced today that it has received an additional $1.5 million in funding from the National Institutes of Health (NIH) to continue a study testing two devices used in combination on those who experience cardiac arrest outside a hospital. Parts of Oakland and Macomb counties and Livingston County in Michigan are among six sites included in the national study.

The study is needed because of the dismally low survival rates for cardiac arrest; the national average for surviving such a cardiac arrest that occurs outside a hospital setting is only one in twenty.

The NIH funding will be used to increase enrollment in the six-site study. The study involves the testing of the ResQPump(R) an active compression/decompression device, in combination with the ResQPOD(R), a device used to increase blood flow to the heart and brain during CPR. The ResQPOD, an impedance threshold device proven to increase circulation, has previously received clearance from the FDA and is in use at more than 1,100 customer sites in the US. The current NIH funded study is the first randomized study in the US to assess results of the ResQPump and ResQPOD used together and comparing results when CPR is performed without these devices. The ResQPump has been tested and is currently in use in Europe. Both devices are designed and manufactured by Advanced Circulatory Systems of Minneapolis, MN.

The six sites involved in the study include Minneapolis, MN; St. Paul, MN; Whatcom County, WA; Oshkosh, WI; suburban Detroit including parts of Oakland and Macomb counties, MI; and Livingston County, MI which includes the city of Ann Arbor.

The use of new technologies as well as improved CPR procedures as recommended by the American Heart Association in its latest guidelines are intended to help more people survive a cardiac arrest and with their brain function intact. Studies like the NIH funded study are believed to be among the best methods to prove how treatments can impact outcomes.

Advanced Circulatory Systems' mission is to restore life and improve the quality of life for patients suffering cardiac arrest, low blood pressure and head injury by developing new technologies to non-invasively increase circulation throughout the body, providing improved opportunity for survival and quality of life. The privately held company is based in Minneapolis, MN.

Media contact: Joanne Henry, 612-843-2142, jhenry@henryschafer.com

Advanced Circulatory Systems medical contact: Keith Lurie, M.D., Chief Medical Officer, 952-947-9590, klurie@advancedcirculatory.com

The generally cleared indication for the ResQPOD is a temporary increase in blood circulation during emergency care, hospital, clinic and home use. Studies are ongoing in the United States to evaluate the long-term benefit of the ResQPOD for indications related to patients suffering from cardiac arrest, hypotension during dialysis and severe blood loss. The references in this communication are not intended to imply specific outcome-based claims not yet cleared by the US Food and Drug Administration. Clinical study references are available upon request.


'/>"/>
SOURCE Advanced Circulatory Systems, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Blue Cross Blue Shield of Michigan Corrects News Story about Drug Coverage Announcement
2. Education Key Focus of Michigan Policy Summit
3. Michigan Hospitals Receive Governors Award
4. Blue Cross Blue Shield of Michigan Offers New Approach to Customer Group Wellness
5. ProAssurance Group Offers Coverage for Community Based Hospitals in Michigan
6. Blue Care Network of Michigan Earns National Leadership Award for Chronic Disease Management
7. Eight Michigan HMOs, Two Providers, Take Top Honors for Quality Health Care
8. Northern Michigan Regional Health System Named a Working Mother 100 Best Company - 2007 by Working Mother Magazine
9. Blue Cross Blue Shield of Michigan Launches Effort in Five Michigan Cities with Department of Community Health to Enroll Uninsured Children in MIChild
10. Michigan Catholic Conference Launches Massive Internal Stem Cell Education Program
11. NanoBio Wins 2007 Michigan Innovation Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty Network, ... M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... the most handsome men, look naturally attractive. Plastic surgery should be invisible.” He ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... , June 24, 2016 ... has announced the addition of the " Global ... This report ... provides an updated review, including its applications in various ... total market, which includes three main industries: pharmaceutical and ...
(Date:6/24/2016)... 2016 The Academy of Managed Care Pharmacy ... that would allow biopharmaceutical companies to more easily share ... formulary and coverage decisions, a move that addresses the ... The recommendations address restrictions in the sharing ... drug label, a prohibition that hinders decision makers from ...
Breaking Medicine Technology: